These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36169687)

  • 1. Apparent diffusion coefficient for assessing Crohn's disease activity: a meta-analysis.
    Thormann M; Melekh B; Bär C; Pech M; Omari J; Wienke A; Meyer HJ; Surov A
    Eur Radiol; 2023 Mar; 33(3):1677-1686. PubMed ID: 36169687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Boyer L; Pereira B; Bommelaer G
    Aliment Pharmacol Ther; 2015 Aug; 42(4):452-60. PubMed ID: 26088810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion kurtosis MRI versus conventional diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease.
    Huang L; Li XH; Huang SY; Zhang ZW; Yang XF; Lin JJ; Jiang MJ; Feng ST; Sun CH; Li ZP
    J Magn Reson Imaging; 2018 Mar; 47(3):702-709. PubMed ID: 28577319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Scanzi J; Goutorbe F; Klotz T; Boyer L; Pereira B; Bommelaer G
    Dig Liver Dis; 2016 Mar; 48(3):260-6. PubMed ID: 26699828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion and perfusion MRI quantification in ileal Crohn's disease.
    Hectors SJ; Gordic S; Semaan S; Bane O; Hirten R; Jia X; Colombel JF; Taouli B
    Eur Radiol; 2019 Feb; 29(2):993-1002. PubMed ID: 30019143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of inflammatory activity in patients with Crohn's disease using diffusion weighted imaging (DWI) in MR enteroclysis and MR enterography.
    Stanescu-Siegmund N; Nimsch Y; Wunderlich AP; Wagner M; Meier R; Juchems MS; Beer M; Schmidt SA
    Acta Radiol; 2017 Mar; 58(3):264-271. PubMed ID: 27178031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease.
    Faletti R; Ribaldone DG; Gatti M; Perazzini C; Robella M; Angelino F; Saracco GM; Astegiano M; Pellicano R; Fonio P
    Rev Esp Enferm Dig; 2019 Jan; 111(1):28-33. PubMed ID: 30284909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADC Values for Detecting Bowel Inflammation and Biologic Therapy Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis.
    Rimola J; Fernandez-Clotet A; Capozzi N; Caballol B; Rodríguez S; Gallego M; Masamunt MC; Panés J; Ricart E; Ordás I
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329639. PubMed ID: 37584507
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity.
    Hordonneau C; Buisson A; Scanzi J; Goutorbe F; Pereira B; Borderon C; Da Ines D; Montoriol PF; Garcier JM; Boyer L; Bommelaer G; Petitcolin V
    Am J Gastroenterol; 2014 Jan; 109(1):89-98. PubMed ID: 24247212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance Index of Activity (MaRIA) is reliable in assessing response to treatment in patients with Crohn's disease (CD).
    Zhang YN; Liu YB; Xu J; Cao KM; Zhang XX; Wang YB; Liu F; Duan BS; Hu YD; Chu SG
    Clin Radiol; 2024 Mar; 79(3):230-236. PubMed ID: 38092646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of magnetic resonance index of activity (MaRIA) in the preoperative assessment of small bowel Crohn's disease.
    Pous-Serrano S; Frasson M; Pàmies-Guilabert J; Rudenko P; Puchades-Román I; Beltrán B; Nos Mateu P; García-Granero E
    Cir Esp (Engl Ed); 2019 Dec; 97(10):582-589. PubMed ID: 31585676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenteric lymph nodes in MR enterography: are they reliable followers of bowel in active Crohn's disease?
    Radmard AR; Eftekhar Vaghefi R; Montazeri SA; Naybandi Atashi S; Hashemi Taheri AP; Haghighi S; Salehnia A; Dadgostar M; Malekzadeh R
    Eur Radiol; 2018 Oct; 28(10):4429-4437. PubMed ID: 29696432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Li XH; Sun CH; Mao R; Huang SY; Zhang ZW; Yang XF; Huang L; Lin JJ; Zhang J; Ben-Horin S; Feng ST; Chen MH; Li ZP
    Inflamm Bowel Dis; 2017 Feb; 23(2):244-253. PubMed ID: 28079618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study.
    Coimbra A; Rimola J; Cuatrecasas M; De Hertogh G; Van Assche G; Vanslembrouck R; Glerup H; Nielsen AH; Hagemann-Madsen R; Bouhnik Y; Zappa M; Cazals-Hatem D; D'Haens G; Stoker J; Meijer S; Rogler G; Boss A; Weber A; Zhao R; Keir ME; Scherl A; de Crespigny A; Lu TT; Panés J
    Clin Transl Gastroenterol; 2022 Jul; 13(7):e00505. PubMed ID: 35905415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI for Staging of Bowel Inflammatory Activity in Crohn's Disease with MUSE-IVIM and DCE-MRI: A Preliminary Study.
    Mao L; Li Y; Cui B; Lu L; Dou W; Pylypenko D; Zhu J; Li H
    Acad Radiol; 2024 Mar; 31(3):880-888. PubMed ID: 37730492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease?
    Foti PV; Travali M; Farina R; Palmucci S; Coronella M; Spatola C; Puzzo L; Garro R; Inserra G; Riguccio G; Zanoli L; Basile A
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803953
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience.
    Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW
    Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease.
    Zhu J; Zhang F; Luan Y; Cao P; Liu F; He W; Wang D
    Medicine (Baltimore); 2016 Apr; 95(14):e3239. PubMed ID: 27057860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.